- Conditions: Lung Cancer; Cancer of Lung; Pulmonary Cancer; Pulmonary Neoplasms; Carcinoma, Small Cell
Intervention: Drug: Arsenic Trioxide
Sponsors: Emory University; Emory University; Cephalon
Recruiting - verified May 2012 - Condition: Leukemia
Interventions: Drug: ATRA; Drug: ATO; Drug: GO (Gemtuzumab ozogamicin); Drug: Methylprednisolone
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Pfizer
Recruiting - verified March 2012 - Condition: Acute Promyelocytic Leukemia
Intervention: Drug: Tretinoin and Arsenic Trioxide
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Northwestern University; New York Presbyterian Hospital; University of Southern California; Princess Margaret Hospital, Canada; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Arsenic trioxide
Sponsors: Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH); Cephalon
Recruiting - verified March 2012 - Condition: Cancer Other Than Leukemia
Intervention: Drug: Arsenic Trioxide
Sponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio
Recruiting - verified February 2012 - Condition: Primary Myelofibrosis
Intervention: Drug: Dose Escalating Arsenic Trioxide plus ascorbic Acid
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; Cephalon
Recruiting - verified February 2012 - Condition: Leukemia
Interventions: Drug: arsenic trioxide; Drug: cytarabine; Drug: idarubicin; Drug: mercaptopurine; Drug: methotrexate; Drug: mitoxantrone hydrochloride; Drug: tretinoin; Genetic: cytogenetic analysis; Genetic: polymerase chain reaction; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Leukemia
Interventions: Drug: arsenic trioxide; Drug: gemtuzumab ozogamicin; Drug: mercaptopurine; Drug: methotrexate; Drug: tretinoin
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified November 2011 - Condition: Acute Promyelocytic Leukemia
Intervention: Drug: Tamibarotene
Sponsors: CytRx; CytRx
Recruiting - verified March 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: arsenic trioxide; Drug: temozolomide; Radiation: radiation therapy
Sponsors: Northwestern University; Northwestern University; Cephalon; Cell Therapeutics
Recruiting - verified May 2012
 |
Arsenic Trioxide Clinical Trials |
